Research has consistently demonstrated racial and ethnic disparities among patients with rheumatoid arthritis. Rheumatology Advisor interviewed one of the authors of a recent study, Isabel Castrejon, to learn more about these disparities and any potential solutions.
Researchers found that using genes as biomarkers to identify the optimal therapy might potentially someday benefit patients with rheumatoid arthritis.
Results of an investigational US pilot study have shown that a proprietary bioelectronic microregulator device, manufactured by SetPoint Medical, can benefit patients with rheumatoid arthritis.
Investigators continue to find advanced radiologic imaging techniques for surgeons to use during interventions in cervical spine involvement in rheumatoid arthritis.